Press releases – Calliditas Therapeutics AB

Read the latest press releases from Calliditas Therapeutics by clicking on a title below.

For press enquiries please contact us.

Dec 23, 2019

The pivotal Phase 3 clinical trial NefIgArd Part A fully recruited

Nov 4, 2019

Calliditas Therapeutics Capital Markets Day today November 4

Oct 1, 2019

Save the date: Calliditas to host Capital Markets Day in Stockholm on November 4, 2019

Aug 12, 2019

Calliditas Therapeutics to host conference call to provide Business Update and 2019 Q2 report

Jun 4, 2019

Calliditas Therapeutics to Present at Redeye Growth Day

May 6, 2019

Calliditas Therapeutics to host conference call to provide Business Update and 2019 Q1 report

Apr 5, 2019

Elmar Schnee and Diane Parks proposed as new board members of Calliditas Therapeutics

Apr 3, 2019

Calliditas Therapeutics to Present at the Needham Healthcare Conference

Mar 4, 2019

Calliditas Therapeutics to Present at March Investor Conferences

Feb 1, 2019

Calliditas Therapeutics to host conference call to provide Business Update and 2018 full-year report

Jan 14, 2019

Calliditas Therapeutics appoints Frank Bringstrup as VP Regulatory Affairs

Jan 8, 2019

Calliditas Therapeutics appoints Andrew Udell to VP Commercial, North America